» Articles » PMID: 20150258

Targeted Contrast-enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-binding Knottin Peptides

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 2010 Feb 13
PMID 20150258
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Targeted contrast-enhanced ultrasound imaging is increasingly being recognized as a powerful imaging tool for the detection and quantification of tumor angiogenesis at the molecular level. The purpose of this study was to develop and test a new class of targeting ligands for targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with small, conformationally constrained peptides that can be coupled to the surface of ultrasound contrast agents.

Methods: Directed evolution was used to engineer a small, disulfide-constrained cystine knot (knottin) peptide that bound to alpha(v)beta(3) integrins with a low nanomolar affinity (Knottin(Integrin)). A targeted contrast-enhanced ultrasound imaging contrast agent was created by attaching Knottin(Integrin) to the shell of perfluorocarbon-filled microbubbles (MB-Knottin(Integrin)). A knottin peptide with a scrambled sequence was used to create control microbubbles (MB-Knottin(Scrambled)). The binding of MB-Knottin(Integrin) and MB-Knottin(Scrambled) to alpha(v)beta(3) integrin-positive cells and control cells was assessed in cell culture binding experiments and compared with that of microbubbles coupled to an anti-alpha(v)beta(3) integrin monoclonal antibody (MB(alphavbeta3)) and microbubbles coupled to the peptidomimetic agent c(RGDfK) (MB(cRGD)). The in vivo imaging signals of contrast-enhanced ultrasound with the different types of microbubbles were quantified in 42 mice bearing human ovarian adenocarcinoma xenograft tumors by use of a high-resolution 40-MHz ultrasound system.

Results: MB-Knottin(Integrin) attached significantly more to alpha(v)beta(3) integrin-positive cells (1.76 +/- 0.49 [mean +/- SD] microbubbles per cell) than to control cells (0.07 +/- 0.006). Control MB-Knottin(Scrambled) adhered less to alpha(v)beta(3) integrin-positive cells (0.15 +/- 0.12) than MB-Knottin(Integrin). After blocking of integrins, the attachment of MB-Knottin(Integrin) to alpha(v)beta(3) integrin-positive cells decreased significantly. The in vivo ultrasound imaging signal was significantly higher after the administration of MB-Knottin(Integrin) than after the administration of MB(alphavbeta3) or control MB-Knottin(Scrambled). After in vivo blocking of integrin receptors, the imaging signal after the administration of MB-Knottin(Integrin) decreased significantly (by 64%). The imaging signals after the administration of MB-Knottin(Integrin) were not significantly different in the groups of tumor-bearing mice imaged with MB-Knottin(Integrin) and with MB(cRGD). Ex vivo immunofluorescence confirmed integrin expression on endothelial cells of human ovarian adenocarcinoma xenograft tumors.

Conclusion: Integrin-binding knottin peptides can be conjugated to the surface of microbubbles and used for in vivo targeted contrast-enhanced ultrasound imaging of tumor angiogenesis. Our results demonstrate that microbubbles conjugated to small peptide-targeting ligands provide imaging signals higher than those provided by a large antibody molecule.

Citing Articles

BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model.

Courcier J, Leguerney I, Benatsou B, Pochon S, Tardy I, Albiges L Int J Mol Sci. 2023; 24(22).

PMID: 38003400 PMC: 10671137. DOI: 10.3390/ijms242216211.


Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy.

Kancheva M, Aronson L, Pattilachan T, Sautto F, Daines B, Thommes D J Funct Biomater. 2023; 14(7).

PMID: 37504868 PMC: 10382061. DOI: 10.3390/jfb14070373.


Characterization of spatially mapped volumetric molecular ultrasound signals for predicting response to anti-vascular therapy.

Keller C, Zarkesh S, Zhou J, Lutz A, Hristov D, Kamaya A Sci Rep. 2023; 13(1):1686.

PMID: 36717575 PMC: 9886917. DOI: 10.1038/s41598-022-26273-0.


Hexapeptides from mammalian inhibitory hormone hunt activate and inactivate nematode reproduction.

Hart J, Mohan S, Davies K, Ferneyhough B, Clarke I, Hunt J PLoS One. 2022; 17(12):e0278049.

PMID: 36454864 PMC: 9714824. DOI: 10.1371/journal.pone.0278049.


Janus USPION modular platform (JUMP) for theranostic ultrasound-mediated targeted intratumoral microvascular imaging and DNA/miRNA delivery.

Whitaker R, Decano J, Gormley C, Beigie C, Meisel C, Tan G Theranostics. 2022; 12(18):7646-7667.

PMID: 36451861 PMC: 9706579. DOI: 10.7150/thno.78454.


References
1.
Brown C, Modzelewski R, Johnson C, Wong M . A novel approach for the identification of unique tumor vasculature binding peptides using an E. coli peptide display library. Ann Surg Oncol. 2000; 7(10):743-9. DOI: 10.1007/s10434-000-0743-0. View

2.
Willmann J, van Bruggen N, Dinkelborg L, Gambhir S . Molecular imaging in drug development. Nat Rev Drug Discov. 2008; 7(7):591-607. DOI: 10.1038/nrd2290. View

3.
Lyshchik A, Fleischer A, Huamani J, Hallahan D, Brissova M, Gore J . Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. J Ultrasound Med. 2007; 26(11):1575-86. PMC: 2634836. DOI: 10.7863/jum.2007.26.11.1575. View

4.
Willmann J, Paulmurugan R, Chen K, Gheysens O, Rodriguez-Porcel M, Lutz A . US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology. 2008; 246(2):508-18. PMC: 4157631. DOI: 10.1148/radiol.2462070536. View

5.
Craik D, Clark R, Daly N . Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins. Expert Opin Investig Drugs. 2007; 16(5):595-604. DOI: 10.1517/13543784.16.5.595. View